Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 31 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
L-LPHARMA from Vosselaar, company number BE0666963585, closed financial year 2025 with a result of € 128,582 after tax. For that financial year L-LPHARMA recorded a gross margin of € 185,025 and equity of € 593,621. Compared with financial year 2024, the result moved from € 66,037 to € 128,582. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.
€ 593,621
▲ 16% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 128,582
▲ 95% vs 2024
Profit after tax over the fiscal year.
€ 6,124
▲ 12% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 45,000 paid out
35 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 562
▼ 91% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 407,542
▼ 14% vs 2024
€ 65,236 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.
€ 3,398
▼ 59% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 67,345
▼ 3% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 135,452 | € 148,483 | € 117,101 | € 185,025 | ▲ 58% |
| Profit after taxes | € 89,836 | € 100,601 | € 66,037 | € 128,582 | ▲ 95% |
| Equity | € 382,202 | € 437,803 | € 510,040 | € 593,621 | ▲ 16% |
| Total debts | € 968,418 | € 871,521 | € 751,566 | € 724,612 | ▼ 4% |
| Cash | € 5,251 | € 11,140 | € 5,480 | € 6,124 | ▲ 12% |
| Retained profit | € 369,802 | € 425,403 | € 491,440 | € 575,021 | ▲ 17% |
| Dividend | € 0 | € 45,000 | € 0 | € 45,000 | |
| Bank debt | € 610,857 | € 542,405 | € 472,822 | € 407,542 | ▼ 14% |
| Balance sheet total | € 1,350,620 | € 1,309,324 | € 1,261,605 | € 1,318,233 | ▲ 4% |
Key figures of L-LPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to L-LPHARMA?
What happened at L-LPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 128,582 (▲ 95% vs 2024). Source: NBB ↗
- New establishment in Vosselaar. KBO
- Lynn Leemans became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 89,836 profit in 2022 to € 128,582 profit in 2025.
Paid € 118,786 in corporate taxes since 2022.
Best year ever: 2025, with € 128,582 profit.
Paid out € 90,000 in dividends to the owners in total.
Management
Behind L-LPHARMA is Lynn Leemans. It owns 99% of Apotheek De Vrijheid itself.
Directors
According to the 2025 annual accounts
since 2016
Establishments
Establishment units
Physical locations of this company
Commerdaelseweg 9
2350 Vosselaar
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
CLOUDFLARENET - Cloudflare, Inc., US
DNS
Cloudflare DNS
Website info
Features
Security
Network
Details
- Company number
- 0666.963.585
- VAT number
- BE 0666.963.585
- Registered office
- Commerdaelseweg 9, 2350 Vosselaar
- Names & denominations
- L-LPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 December 2016
- Peppol
- Active · Active since 24 Nov 2023
- Contact
- apotheekdevrijheid.be
- Activities · NACE
Activiteiten van holdings
Holdings
Overige zakelijke dienstverlening, neg